Reteplase

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Reteplase is a recombinant plasminogen activator which is a modification of the classical tissue plasminogen activator molecule. The fibrin specificity is lower compared to the Tissue Plasminogen Activator, but has a significantly extended half-life of 18 minutes.

Preparations
This section has been translated automatically.

Rapilysin®

Literature
This section has been translated automatically.

  1. HA Neumann (2014) The coagulation system. ABW-Scientific Publisher GmbH Berlin

Recommended articles

Dermatology
Graft-versus-Host-Disease: chronic. 1.5 years after stem cell transplantation, large-area, sclero...
Graft-versus-host disease chronic

Complex multi-organ disease that occurs 3-5 months or later after allogeneic hematopoietic stem cell transp...

Continue reading
Internal medicine
LA-MRSA in pigs

LA-MRSA is the acronym for "Livestock-associated MRSA", where MRSA stands for methicillin-resistant Staphyl...

Continue reading
Advertisment
Vascular medicine
lymphedema secondary: diffuse, uniform swelling of the left lower extremity. if the patient stand...
Lymphedema secondary

Acquired, unilateral or bilateral lymphedema as a result of acquired disturbances in lymph transport. S.a.u...

Continue reading
Vascular medicine
Sturge weber syndrome

Sturge-Weber syndrome, also known as "encephalofacial angiomatosis" or "Sturge-Weber-Krabbe syndrome", is a...

Continue reading
Advertisment

Outgoing links (1)

Tissue plasminogen activator;

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer Prof. Dr. med. Peter Altmeyer

Articlecontent